MicroRNA-423 enhances the invasiveness of hepatocellular carcinoma via regulation of BRMS1.
This study sheds light on miR-423 as a crucial factor that enhances HCC cell invasiveness, and suggests miR-423 as a promising therapeutic target for HCC treatment.
PMID: 29312509 [PubMed]
Source: American Journal of Translational Research - Category: Research Tags: Am J Transl Res Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Genetics | Hepatocellular Carcinoma | Liver | Liver Cancer | Research | Study | Urology & Nephrology